A pilot study evaluating the efficacy of botulinum toxin A in the treatment of Raynaud phenomenon

J Am Acad Dermatol. 2013 Nov;69(5):834-835. doi: 10.1016/j.jaad.2013.06.029.

Authors

Sasha N Jenkins¹, Kimberly M Neyman², Emir Veledar³, Suephy C Chen³

Affiliations

¹ Department of Dermatology, Emory University, Atlanta, Georgia. Electronic address: sasha.nicole.jenkins@emory.edu.
² Dermatology Associates of Colorado, Aurora, Colorado.
³ Department of Dermatology, Emory University, Atlanta, Georgia.

PMID: 24124825
DOI: 10.1016/j.jaad.2013.06.029

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Botulinum Toxins, Type A / therapeutic use*
Double-Blind Method
Female
Humans
Male
Middle Aged
Pilot Projects
Raynaud Disease / drug therapy*

Substances

Botulinum Toxins, Type A